← All trials
NCT04823260
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 25, 2021
- Primary completion
- Sep 9, 2021
- Completion date
- Sep 9, 2021
- First posted
- Mar 30, 2021
- Last posted
- Oct 1, 2021
- Enrollment
- 90
- Arms / groups
- 6 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Abinopharm, IncLead sponsor
- Abinopharm, IncStudy chair
- ProRelix Services LLPCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.